Authors
Sreten Bogdanovic and Beata LanglandsBiophoenix Ltd, Coventry, CV5 6GS, UK.
Contents
Table of ContentsExecutive Summary
Chapter 1 Introduction
Chapter 2 Biomarkers of atherosclerosis
Chapter 3 Improving mainstay therapies
Chapter 4 Focus on HDL
Chapter 5 Other lipid modulators
Chapter 6 Market outlook
Chapter 7 Market potential
Appendices
Further Information
Press release | brochure | GEN article | word and drug target clouds (?) | free evaluation version | contact us.Prices |  |
| PDF: | $3,000 | €1,920 | £1,500 |
| CHM: | $3,000 | €1,920 | £1,500 |
| Print: | $3,500 | €2,240 | £1,750 |
Notes: UK customers are liable for VAT at 17.5% on electronic versions. $US and € prices are approximate.
